Cordyceps Sunshine Biotech Holdings Cash Flow Statement (2021-2023) | RAJAF

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2021 Dec2022 Sep2023 Dec2023
Operating Activities
Net Income (Quarter) -0.37M-0.30M
Cash from Discontinued Operations (Quarter) -0.09M-0.02M
Cash from Operations (Quarter) -0.11M-1.23M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.12M
Depreciation & Amortization (CF) (Quarter) 0.06M
Change in Working Capital
Change in Receivables (Quarter) 0.01M0.01M0.01M
Change in Inventory (Quarter) 0.31M0.00M0.19M
Change in Account Payables (Quarter) 0.26M
Other Working Capital Changes (Quarter) -0.03M
Investing Activities
Capital Expenditures (Quarter) 1.86M
Divestments (Quarter) -0.00M-0.00M
Cash from Investing Activities (Quarter) -0.00M-1.86M
Financing Activities
Other financing activities (Quarter) -0.02M0.03M
Cash from Financing Activities (Quarter) 0.03M0.02M
Additional items
Exchange Rate Effect (Quarter) 0.10M-0.03M
Change in Cash (Quarter) -0.00M0.00M
Free Cash Flow (Quarter) -0.11M-3.09M
Net Cash Flow (Quarter) -0.08M-3.07M